Clinical preventive services in Guatemala: a cross-sectional survey of internal medicine physicians

Juan E Corral, Lauren D Arnold, Erwin E Argueta, Akshay Ganju, Joaquín Barnoya, Juan E Corral, Lauren D Arnold, Erwin E Argueta, Akshay Ganju, Joaquín Barnoya

Abstract

Background: Guatemala is currently undergoing an epidemiologic transition. Preventive services are key to reducing the burden of non-communicable diseases, and smoking counseling and cessation are among the most cost-effective and wide-reaching strategies. Internal medicine physicians are fundamental to providing such services, and their knowledge is a cornerstone of non-communicable disease control.

Methods: A national cross-sectional survey was conducted in 2011 to evaluate knowledge of clinical preventive services for non-communicable diseases. Interns, residents, and attending physicians of the internal medicine departments of all teaching hospitals in Guatemala completed a self-administered questionnaire. Participants' responses were contrasted with the Guatemalan Ministry of Health (MoH) prevention guidelines and the US Preventive Services Task Force (USPSTF) recommendations. Analysis compared knowledge of recommendations within and between hospitals.

Results: In response to simulated patient scenarios, all services were recommended by more than half of physicians regardless of MoH or USPSTF recommendations. Prioritization was adequate according to the MoH guidelines but not including other potentially effective services (e.g. colorectal cancer and lipid disorder screenings). With the exception of colorectal and prostate cancer screening, less frequently recommended by interns, there was no difference in recommendation rates by level.

Conclusion: Guatemalan internal medicine physicians' knowledge on preventive services recommendations for non-communicable diseases is limited, and prioritization did not reflect cost-effectiveness. Based on these data we recommend that preventive medicine training be strengthened and development of evidence-based guidelines for low-middle income countries be a priority.

Trial registration: ClinicalTrials.gov NCT01515111.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization. Circulation 104: 2746–2753.
    1. PAHO Special Program for Health Analysis (SHA) (2002) Demographic and mortality trends in the region of the Americas, 1980–2000. Epidemiol Bull 23: 1–4.
    1. Albala C, Vio F, Yanez M (1997) [Epidemiological transition in Latin America: a comparison of four countries]. Rev Med Chil 125: 719–727.
    1. Moscoso V, Flores C (2007) Retrato de Muertes Evitables, El sistema de salud en Guatemala ¿hacia dónde vamos?. Guatemala City: Programa de Naciones Unidas para el Desarrollo (PNUD) and Amanuense Editores. 75p.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global Burden of Disease and Risk Factors. New York: Oxford University Press and The World Bank. 475 p.
    1. World Health Organization (2011) Noncommunicable diseases country profiles 2011. Geneva: WHO press. 207 p.
    1. Strong K, Mathers C, Leeder S, Beaglehole R (2005) Preventing chronic diseases: how many lives can we save? Lancet 366: 1578–1582.
    1. Jemal A, Ward E, Thun M (2010) Declining death rates reflect progress against cancer. PLoS One 5: e9584.
    1. Capewell S, Hayes DK, Ford ES, Critchley JA, Croft JB, et al. (2009) Life-years gained among US adults from modern treatments and changes in the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. Am J Epidemiol 170: 229–236.
    1. Unal B, Critchley JA, Fidan D, Capewell S (2005) Life-Years Gained From Modern Cardiological Treatments and Population Risk Factor Changes in England and Wales, 1981–2000. Am J Public Health 95: 103–108.
    1. Palmieri L, Bennett K, Giampaoli S, Capewell S (2010) Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 100: 684–692.
    1. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, et al. (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116: 544–573.
    1. Thun M, Jemal A (2011) How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control: 345–347.
    1. World Health Organization (2012) Cancer Prevention. Geneva: WHO Press. Available: . Accessed 2012 Apr 11.
    1. Centers for Disease Control and Prevention (1999) Ten great public health achievements–United States, 1900–1999. MMWR Morb Mortal Wkly Rep 48: 241–243.
    1. Rose G (1999) The Strategy of Preventive Medicine. London: Oxford University Press. 135 p.
    1. Ministerio de Salud Pública y Asistencia Social, Departamento de Regulación de los Programas de Atención a las Personas (2011) Guías para la prevención, detección, evaluación y tratamiento de las Enfermedades Crónicas No Transmisibles. Guatemala City: Ministerio de Salud Pública y Asistencia Social. 98 p.
    1. Bowser DM, Mahal A (2011) Guatemala: the economic burden of illness and health system implications. Health Policy 100: 159–166.
    1. USPSTF Program Office (2011) U.S. Preventive Services Task Force. Rockville, MD. Available: . Accessed 2012 Apr 11.
    1. Maciosek M, Coffield A, Edwards N, Flottemesch T, Goodman M, et al. (2006) Priorities Among Effective Clinical Preventive Services Results of a Systematic Review and Analysis. Am J Prev Med 31: 52–61.
    1. World Health Organization (2008) WHO Report on the Global Tobacco Epidemic, 2008: the MPOWER package; Geneva: WHO press. 330 p.
    1. Ngoma T (2006) World Health Organization cancer priorities in developing countries. Ann Oncol 17: viii9–viii14.
    1. Merenstein D, Daumit G, Powe N (2006) Use and Costs of Nonrecommended Tests During Routine Preventive Health Exams. Am J Prev Med 30: 521–527.
    1. World Health Organization (2010) Global status report on noncommunicable diseases 2010, Chapter 4 Reducing risks and preventing disease: population-wide interventions; Geneva: WHO press. 14 p.
    1. Viteri E, Barnoya J, Hudmon KS, Solorzano PJ (2011) Smoking cessation medications and cigarettes in Guatemala pharmacies. Tob Control doi:10.1136/tc.2011.044040.
    1. Zack DL, DiBaise JK, Quigley EM, Roy HK (2001) Colorectal cancer screening compliance by medicine residents: perceived and actual. Am J Gastroenterol 96: 3004–3008.
    1. Eisinger F, Blay JY, Morere JF, Rixe O, Calazel-Benque A, et al. (2008) Cancer screening in France: subjects’ and physicians’ attitudes. Cancer Causes Control 19: 431–434.
    1. Kamposioras K, Mauri D, Alevizaki P, Ferentinos G, Karampoiki V, et al. (2008) Cancer screening in Greece. Guideline awareness and prescription behavior among Hellenic physicians. Eur J Intern Med 19: 452–460.
    1. Villarreal-Garza C, Garcia-Aceituno L, Villa AR, Perfecto-Arroyo M, Rojas-Flores M, et al. (2010) Knowledge about cancer screening among medical students and internal medicine residents in Mexico City. J Cancer Educ 25: 624–631.
    1. Tucunduva LT, Sa VH, Koshimura ET, Prudente FV, Santos AF, et al. (2004) [Evaluation of non-oncologist physician’s knowledge and attitude towards cancer screening and preventive actions]. Rev Assoc Med Bras 50: 257–262.
    1. Departamento de Estadística (2011) Registros de Consultas, Consulta Externa Adultos, Medicina Interna, 2010. Guatemala City: Hospital General San Juan de Dios.
    1. Departamento de Estadística (2011) Registro de Pacientes Hospitalizados, Medicina Interna, 2010. Guatemala City: Hospital Roosevelt.
    1. Willett LL, Palonen K, Allison JJ, Heudebert GR, Kiefe CI, et al. (2005) Differences in Preventive Health Quality by Residency Year. Is Seniority Better? J Gen Intern Med 20: 825–829.
    1. An P, Ashburner J, Fosburgh B, Atlas S (2010) Performance on Preventive Cancer Screening Tests in the Ambulatory Setting by Internal Medicine Resident Physicians. Teach Learn Med 22: 45–49.
    1. Gennarelli M, Jandorf L, Cromwell C, Valdimarsdottir H, Redd W, et al. (2005) Barriers to colorectal cancer screening: inadequate knowledge by physicians. Mt Sinai J Med 72: 36–44.
    1. Agurto I, Bishop A, Sanchez G, Betancourt Z, Robles S (2004) Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med 39: 91–98.
    1. Blumenthal DS (2007) Barriers to the provision of smoking cessation services reported by clinicians in underserved communities. J Am Board Fam Med 20: 272–279.
    1. Sprake C, Cantillon P, Metcalf J, Spencer J (2008) Teaching in an ambulatory care setting. BMJ 337: a1156.
    1. Borum M (1997) Medical Residents’ Colorectal Cancer Screening May Be Dependent on Ambulatory Care Education. Dig Dis Sci 42: 1176–1178.
    1. Celletti F, Reynolds TA, Wright A, Stoertz A, Dayrit M (2011) Educating a New Generation of Doctors to Improve the Health of Populations in Low- and Middle-Income Countries. PLoS Medicine 8: e1001108.
    1. Winawer SJ, Krabshuis J, Lambert R, O'Brien M, Fried M (2011) Cascade colorectal cancer screening guidelines: a global conceptual model. J Clin Gastroenterol 45: 297–300.
    1. Stone DH (1993) Design a questionnaire. BMJ 307: 1264–1266.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir